Colorectal Cancer Clinical Trials

Showing 921-940 of 1,434 trials

A Study of Niclosamide in Patients With Resectable Colon Cancer

NCT02687009

This study evaluates the safety of Niclosamide in patients with colon cancer that are undergoing primary resection of their tumor. This is a phase I study with three dosage levels to determine the maximum tolerated dose (MTD).

Colon Cancer

Michael Morse, MD1 participantsStarted Nov 2017

Durham, North Carolina, United States

COMPLETEDPHASE1/PHASE2

A Dose Finding Study of Eribulin Mesylate and Cetuximab For Patients With Advanced Head and Neck and Colon Cancer

NCT01744340

The purpose of this study is to determine if the full dose of eribulin mesylate can be safely given with the full dose of cetuximab. The activity of the combination of eribulin mesylate and cetuximab on recurrent head and neck cancer and colon cancer will also be assessed.

Head and Neck CancerColon Cancer

howard safran23 participantsStarted May 2012

The Bronx, New York, United States • Pawtucket, Rhode Island, United States • Providence, Rhode Island, United States +1 more locations

TERMINATEDPHASE2

Adjuvant Aflibercept for Metastatic Colorectal Cancer

NCT01669720

The main purpose of this study is to evaluate if aflibercept can reduce the chance that metastatic (spread of) colorectal cancer can grow back after finishing standard treatment. The study will also look at the side effects of aflibercept and the effect on quality of life.

Metastatic Colorectal Cancer

Brown University10 participantsStarted Dec 2012

Providence, Rhode Island, United States • Providence, Rhode Island, United States

A Study of Niclosamide in Patients With Resectable Colon Cancer

A Dose Finding Study of Eribulin Mesylate and Cetuximab For Patients With Advanced Head and Neck and Colon Cancer

Adjuvant Aflibercept for Metastatic Colorectal Cancer

Related Searches

Three-port Versus Conventional Laparoscopic Surgery for Colorectal Cancer

Paired Analysis of Sensitivity for Colorectal Cancer Using COLVERA : PASCAL

Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients

Small Media Interventions to Increase Colorectal Cancer Screening Among Chinese Americans

Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers

Validation of Colon Biomarkers for the Early Detection of Colorectal Adenocarcinoma

The Diagnosis of Invasive Depth of Early Rectal Cancer

Volatile Organic Compounds (VOCs) Profile in Colorectal Cancer Patients and Healthy Controls.

Individualization of Dosage of Irinotecan in the FOLFIRI According to the Genetic Polymorphism of UGT1A1 in the First Line Treatment of Metastatic Colorectal Cancer

Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART133

Analysis of the Effectiveness of Neoadjuvant Chemotherapy in the Treatment of Colon Cancer Locally Advanced (ELECLA)

Evaluation of Hypertension as a Predictor of Efficacy Bevacizumab in Metastatic Breast Cancer and Colorectal Cancer

mXELOXIRI Combined With Molecular Targeted Drug in mCRC

Interactive Cancer Communication System (ICCS) Directed Physical Activity Enhancement for Colon Cancer Survivors

Acupuncture to Prevent Chemotherapy Dose Reduction Due to Chemotherapy-induced Peripheral Neuropathy in Breast and Colorectal Cancer Patients (GCC1232)

A Preliminary Clinical Study on the Pharmacokinetics and Safety of CDP1 in Patients With Advanced CRC or HNSCC

Natural Compounds to Reduce Nitrite in Meat Products